Literature DB >> 11909620

The nurse specialist as main care-provider for patients with type 2 diabetes in a primary care setting: effects on patient outcomes.

H J M Vrijhoef1, J P M Diederiks, C Spreeuwenberg, B H R Wolffenbuttel, L J G P van Wilderen.   

Abstract

A solution to safeguard high quality diabetes care may be to allocate care to the nurse specialist. By using a one group pretest-posttest design with additional comparisons, this study evaluated effects on patient outcomes of a shared care model with the diabetes nurse as main care-provider for patients with type 2 diabetes in a primary care setting. The shared care model resulted in an improved glycaemic control, additional consultations and other outcomes being equivalent to diabetes care before introduction, with the general practitioner as main care-provider. Assignment of care for patients with type 2 diabetes to nurse specialists seems to be justified.

Entities:  

Mesh:

Year:  2002        PMID: 11909620     DOI: 10.1016/s0020-7489(01)00046-3

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  13 in total

1.  Association between registered nurse staffing and management outcomes of patients with type 2 diabetes within primary care: a cross-sectional linkage study.

Authors:  Julia Lukewich; Dana S Edge; Elizabeth VanDenKerkhof; Tyler Williamson; Joan Tranmer
Journal:  CMAJ Open       Date:  2016-06-03

2.  Healthcare system design and parttime working doctors.

Authors:  J J W Molema; S Groothuis; I J Baars; M Kleinschiphorst; E G E Leers; A Hasman; G G van Merode
Journal:  Health Care Manag Sci       Date:  2007-12

3.  Psychological risk factors of micro- and macrovascular outcomes in primary care patients with type 2 diabetes: rationale and design of the DiaDDZoB Study.

Authors:  Giesje Nefs; François Pouwer; Johan Denollet; Victor Jm Pop
Journal:  BMC Public Health       Date:  2010-07-01       Impact factor: 3.295

4.  Implementation of integrated care for diabetes mellitus type 2 by two Dutch care groups: a case study.

Authors:  Loraine Busetto; Katrien Luijkx; Anna Huizing; Bert Vrijhoef
Journal:  BMC Fam Pract       Date:  2015-08-21       Impact factor: 2.497

5.  Effectiveness of a supportive telephone counseling intervention in type 2 diabetes patients: randomized controlled study.

Authors:  Ute Mons; Elke Raum; Heike U Krämer; Gernot Rüter; Dietrich Rothenbacher; Thomas Rosemann; Joachim Szecsenyi; Hermann Brenner
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 6.  Exploration of workforce changes in integrated chronic care: Findings from an interactive and emergent research design.

Authors:  Loraine Busetto; Katrien Luijkx; Stefano Calciolari; Laura Guadalupe González Ortiz; Hubertus Johannes Maria Vrijhoef
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

7.  The role of nurse specialists in the delivery of integrated diabetes care: a cross-sectional survey of diabetes nurse specialist services.

Authors:  Fiona Riordan; Sheena M McHugh; Katie Murphy; Julie Barrett; Patricia M Kearney
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

8.  The relationship between context, structure, and processes with outcomes of 6 regional diabetes networks in Europe.

Authors:  Mahdi Mahdavi; Jan Vissers; Sylvia Elkhuizen; Mattees van Dijk; Antero Vanhala; Eleftheria Karampli; Raquel Faubel; Paul Forte; Elena Coroian; Joris van de Klundert
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

9.  Barriers and Facilitators to Workforce Changes in Integrated Care.

Authors:  Loraine Busetto; Katrien Luijkx; Stefano Calciolari; Laura Guadalupe González Ortiz; Hubertus Johannes Maria Vrijhoef
Journal:  Int J Integr Care       Date:  2018-06-01       Impact factor: 5.120

10.  Nursing consultations and control of diabetes in general practice: a retrospective observational study.

Authors:  Trevor Murrells; Jane Ball; Jill Maben; Mark Ashworth; Peter Griffiths
Journal:  Br J Gen Pract       Date:  2015-10       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.